Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer

• Case describes a response to sunitinib in clear cell ovarian cancer. • Discussion of unique molecular characteristics of clear cell ovarian cancers; • Practical points regarding dosing and toxicity when using sunitinib discussed.

Detalles Bibliográficos
Autores principales: Alifrangis, C, Thornton, A, Fotopoulou, C, Krell, J, Gabra, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107646/
https://www.ncbi.nlm.nih.gov/pubmed/27872893
http://dx.doi.org/10.1016/j.gore.2016.11.001
_version_ 1782467222186229760
author Alifrangis, C
Thornton, A
Fotopoulou, C
Krell, J
Gabra, H
author_facet Alifrangis, C
Thornton, A
Fotopoulou, C
Krell, J
Gabra, H
author_sort Alifrangis, C
collection PubMed
description • Case describes a response to sunitinib in clear cell ovarian cancer. • Discussion of unique molecular characteristics of clear cell ovarian cancers; • Practical points regarding dosing and toxicity when using sunitinib discussed.
format Online
Article
Text
id pubmed-5107646
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-51076462016-11-21 Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer Alifrangis, C Thornton, A Fotopoulou, C Krell, J Gabra, H Gynecol Oncol Rep Case Report • Case describes a response to sunitinib in clear cell ovarian cancer. • Discussion of unique molecular characteristics of clear cell ovarian cancers; • Practical points regarding dosing and toxicity when using sunitinib discussed. Elsevier 2016-11-06 /pmc/articles/PMC5107646/ /pubmed/27872893 http://dx.doi.org/10.1016/j.gore.2016.11.001 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Alifrangis, C
Thornton, A
Fotopoulou, C
Krell, J
Gabra, H
Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer
title Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer
title_full Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer
title_fullStr Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer
title_full_unstemmed Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer
title_short Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer
title_sort response to sunitinib (sutent) in chemotherapy refractory clear cell ovarian cancer
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107646/
https://www.ncbi.nlm.nih.gov/pubmed/27872893
http://dx.doi.org/10.1016/j.gore.2016.11.001
work_keys_str_mv AT alifrangisc responsetosunitinibsutentinchemotherapyrefractoryclearcellovariancancer
AT thorntona responsetosunitinibsutentinchemotherapyrefractoryclearcellovariancancer
AT fotopoulouc responsetosunitinibsutentinchemotherapyrefractoryclearcellovariancancer
AT krellj responsetosunitinibsutentinchemotherapyrefractoryclearcellovariancancer
AT gabrah responsetosunitinibsutentinchemotherapyrefractoryclearcellovariancancer

Ejemplares similares